3.99 USD
+0.00
0.00%
Updated Apr 30, 11:48 AM EDT
1 day
0.00%
5 days
-1.48%
1 month
-13.07%
3 months
-30.00%
6 months
-37.75%
Year to date
-32.26%
1 year
-21.92%
5 years
-86.71%
10 years
-86.71%
 

About: FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.

Employees: 316

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

817% more call options, than puts

Call options by funds: $12.8M | Put options by funds: $1.4M

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

2.83% less ownership

Funds ownership: 77.24% [Q3] → 74.41% (-2.83%) [Q4]

9% less funds holding

Funds holding: 185 [Q3] → 169 (-16) [Q4]

13% less capital invested

Capital invested by funds: $853M [Q3] → $744M (-$110M) [Q4]

29% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 42

37% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 67

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$3.75
6%
downside
Avg. target
$5
25%
upside
High target
$7
75%
upside

3 analyst ratings

positive
0%
neutral
67%
negative
33%
Goldman Sachs
Brooke Roach
44% 1-year accuracy
16 / 36 met price target
6%downside
$3.75
Sell
Maintained
22 Apr 2025
Morgan Stanley
Lauren Schenk
91% 1-year accuracy
20 / 22 met price target
7%upside
$4.25
Equal-Weight
Maintained
17 Apr 2025
Telsey Advisory Group
Dana Telsey
30% 1-year accuracy
54 / 182 met price target
75%upside
$7
Market Perform
Maintained
28 Feb 2025

Financial journalist opinion

Based on 3 articles about FIGS published over the past 30 days

Neutral
Business Wire
1 week ago
FIGS Announces Date of First Quarter 2025 Earnings Release, Conference Call and Webcast
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a first quarter 2025 fin.
FIGS Announces Date of First Quarter 2025 Earnings Release, Conference Call and Webcast
Neutral
Seeking Alpha
3 weeks ago
Stock Picks From Seeking Alpha's March 2025 New Analysts
In March, we welcomed 30 new analysts to Seeking Alpha, and in this article we are showcasing their stock picks and investment strategies. Our analysts covered a diverse set of industries—including IT, financials, utilities, materials, and mining—and provided ratings ranging from Strong Sell to Strong Buy. Top picks include C3.ai, Robinhood, Central Puerto, CF Industries, and Kyndryl.
Stock Picks From Seeking Alpha's March 2025 New Analysts
Neutral
Business Wire
3 weeks ago
FIGS Adds Digital Marketing Executive Jerry Jao as New Independent Director to Its Board of Directors
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced the appointment of Jerry Jao, former Chief Executive Officer of Retention Science, to its board of directors (the “Board”), effective April 1, 2025 (the “Effective Date”). Mr. Jao joins the Board as an independent director and has also been appointed to serve as both Chair of the Board's Audit Co.
FIGS Adds Digital Marketing Executive Jerry Jao as New Independent Director to Its Board of Directors
Positive
Seeking Alpha
1 month ago
Figs, Inc. - Slow Growth Is Still Growth
Figs, Inc. is undervalued, as strong private equity interest and a robust balance sheet indicate potential for significant returns. Favorable growth trends in healthcare employment and broader market appeal support optimistic revenue projections for Figs, Inc. Derived equity value suggests a 25% upside from the current share price, highlighting market undervaluation post-IPO.
Figs, Inc. - Slow Growth Is Still Growth
Neutral
Seeking Alpha
1 month ago
FIGS Shows Significant U.S. Weakness But Continues To Trade At 50x NOPAT
FIGS, Inc.'s earnings show mixed results, with strong international growth but declining U.S. sales and weak FY25 guidance, raising concerns about profitability and customer acquisition. Despite strong product innovation, FIGS struggles with high marketing costs, poor customer acquisition, and stagnating U.S. sales, making its high valuation unjustifiable. International expansion is promising but comes with lower margins; new management might improve execution, but significant challenges remain.
FIGS Shows Significant U.S. Weakness But Continues To Trade At 50x NOPAT
Positive
Zacks Investment Research
2 months ago
Figs (FIGS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Figs (FIGS) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Figs (FIGS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Neutral
Seeking Alpha
2 months ago
FIGS, Inc. (FIGS) Q4 2024 Earnings Call Transcript
FIGS, Inc. (NYSE:FIGS ) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Tom Shaw - Senior Vice President, Investor Relations Trina Spear - Co-Founder & Chief Executive Officer Sarah Oughtred - Chief Financial Officer Conference Call Participants Brooke Roach - Goldman Sachs Brian Nagel - Oppenheimer John Kernan - TD Cowen Dana Telsey - Telsey Group Lorraine Hutchinson - Bank of America Matt Koranda - ROTH Capital Ashley Owens - KeyBanc Capital Markets Nathan Feather - Morgan Stanley Operator Good afternoon, everyone, and thank you for joining today's FIGS Fourth Quarter Fiscal 2024 Earnings Conference Call. My name is Reagan, and I'll be your moderator today.
FIGS, Inc. (FIGS) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
2 months ago
Figs (FIGS) Q4 Earnings Meet Estimates
Figs (FIGS) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.05 per share a year ago.
Figs (FIGS) Q4 Earnings Meet Estimates
Neutral
Business Wire
2 months ago
FIGS Releases Fourth Quarter and Full Year 2024 Financial Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS) (the “Company”), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today released its fourth quarter and full year 2024 financial results and published a financial highlights presentation on its investor relations website at ir.wearfigs.com/financials/quarterly-results/. Fourth Quarter 2024 Financial Highlights Net revenues were $151.8 million, an increase of 4.8% year over yea.
FIGS Releases Fourth Quarter and Full Year 2024 Financial Results
Positive
Zacks Investment Research
2 months ago
Countdown to Figs (FIGS) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top -and-bottom-line estimates for Figs (FIGS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Countdown to Figs (FIGS) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Charts implemented using Lightweight Charts™